THEOFAN GEORGIA 4/A
4/A · IMMUNE RESPONSE CORP · Filed Aug 12, 2004
Insider Transaction Report
Form 4/AAmended
THEOFAN GEORGIA
VP, Clinical Development
Transactions
- Purchase
Common Stock
2004-08-11$0.70/sh+5,000$3,500→ 10,475 total
Footnotes (1)
- [F1]The wrong Transaction Code was used on the original filing.